Vetigenics Raises $10 Million for Pet Cancer Treatment Trials
The company will use the funds to further advance its lead cancer therapies for dogs and cats through pivotal clinical trials.
Agni Semiconductor Receives $5 Million Strategic Investment
Agni is developing a high speed, low power, multi-bit non-volatile memory based on Penn technology.
Ascidian Therapeutics and Eli Lilly Establish Global Research Partnership
Ascidian was founded with technology developed by Jean Bennett, MD, PhD.
Exyn Technologies Completes a Successful IPO
Exyn raised $19.4 million in an initial public stock offering in May.
2025 PACT Philadelphia Venture Report Released
The report highlighted several Penn spinouts.
Featured Startup: Nairon Energy
Nairon Energy is building high-voltage sodium-iron batteries to strengthen grid resilience and support long-duration energy storage.
Ultragenyx Reports Promising Phase III Clinical Trial Results for Urea Cycle Disorder Treatment
Ultragenyx’s gene therapy DTX301, based on technology invented by Jim Wilson, MD, PhD, Emeritus Professor at Penn Medicine, helped control ammonia levels in patients with a urea cycle disorder.
Previous President’s Innovation Prize Winners Recognized in Technical.ly’s RealLIST
Both companies are Penn I-Corps graduates.
Serpent Robotics Wins 2026 President’s Innovation Prize
Serpent Robotics, founded by Wharton undergraduate Margaret Zhu, is developing an electric, rope‑climbing robotic system.
Avisi Technologies Raises $11M to Advance Glaucoma Treatment
The funding will support Avisi’s pivotal clinical trial for VisiPlate, a novel glaucoma treatment. device